Package 69918-360-30

{"route": ["ORAL"], "spl_id": "3e1dd650-3c58-44f0-be26-8a7de4cedec5", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0369918360300", "0369918380308", "0369918350301"], "unii": ["U3H27498KS"], "rxcui": ["103968", "198430", "252478", "252479"], "spl_set_id": ["67cf961e-02b9-4a99-944f-43a55df6a544"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Nordic Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69918-360-30)", "package_ndc": "69918-360-30", "marketing_start_date": "20220214"}], "brand_name": "Lamotrigine", "product_id": "69918-360_3e1dd650-3c58-44f0-be26-8a7de4cedec5", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "69918-360", "generic_name": "Lamotrigine", "labeler_name": "Nordic Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "50 mg/1"}], "application_number": "ANDA214124", "marketing_category": "ANDA", "marketing_start_date": "20220214", "listing_expiration_date": "20261231"}